4.8 Editorial Material

Can Dietary Fish Intake Prevent Liver Cancer?

期刊

GASTROENTEROLOGY
卷 142, 期 7, 页码 1411-1413

出版社

W B SAUNDERS CO-ELSEVIER INC
DOI: 10.1053/j.gastro.2012.04.038

关键词

-

向作者/读者索取更多资源

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.8
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

Article Public, Environmental & Occupational Health

Design and methodological considerations for biomarker discovery and validation in the Integrative Analysis of Lung Cancer Etiology and Risk (INTEGRAL) Program

Hilary A. Robbins, Karine Alcala, Elham Khodayari Moez, Florence Guida, Sera Thomas, Hana Zahed, Matthew T. Warkentin, Karl Smith-Byrne, Yonathan Brhane, David Muller, Xiaoshuang Feng, Demetrius Albanes, Melinda C. Aldrich, Alan A. Arslan, Julie Bassett, Christine D. Berg, Qiuyin Cai, Chu Chen, Michael P. A. Davies, Brenda Diergaarde, John K. Field, Neal D. Freedman, Wen-Yi Huang, Mikael Johansson, Michael Jones, Woon-Puay Koh, Stephen Lam, Qing Lan, Arnulf Langhammer, Linda M. Liao, Geoffrey Liu, Reza Malekzadeh, Roger L. Milne, Luis M. Montuenga, Thomas Rohan, Howard D. Sesso, Gianluca Severi, Mahdi Sheikh, Rashmi Sinha, Xiao-Ou Shu, Victoria L. Stevens, Martin C. Tammemaegi, Lesley F. Tinker, Kala Visvanathan, Ying Wang, Renwei Wang, Stephanie J. Weinstein, Emily White, David Wilson, Jian-Min Yuan, Xuehong Zhang, Wei Zheng, Christopher I. Amos, Paul Brennan, Mattias Johansson, Rayjean J. Hung

Summary: The INTEGRAL program aims to develop tools for optimizing LDCT lung cancer screening. It includes the Risk Biomarker and Nodule Malignancy projects, which investigate circulating protein markers for identifying individuals likely to benefit from screening and distinguishing benign versus malignant nodules. A total of 1161 and 1078 proteins were measured, and 21 proteins were selected for performance evaluation in the Risk Biomarker and Nodule Malignancy projects.

ANNALS OF EPIDEMIOLOGY (2023)

Article Oncology

Associations between serum glucose, insulin, insulin resistance and the risk of incident primary liver cancer or chronic liver disease mortality: a nested case-control study

Jian Yin, Neal D. Freedman, Yiwei Liu, Sanford M. M. Dawsey, Huan Yang, Philip R. R. Taylor, Liangyu Yin, Bin Liu, Jianfeng Cui, Jinhu Fan, Wen Chen, Youlin Qiao, Christian C. C. Abnet

Summary: This study found that serum insulin and HOMA-IR may be risk factors for the development of primary liver cancer (PLC) or chronic liver disease (CLD) death. In HBV-positive patients, glucose was also associated with an increased risk of these diseases.

BRITISH JOURNAL OF CANCER (2023)

Article Multidisciplinary Sciences

Inflated expectations: Rare-variant association analysis using public controls

Jung Kim, Danielle M. Karyadi, Stephen W. Hartley, Bin Zhu, Mingyi Wang, Dongjing Wu, Lei Song, Gregory T. Armstrong, Smita Bhatia, Leslie L. Robison, Yutaka Yasui, Brian Carter, Joshua N. Sampson, Neal D. Freedman, Alisa M. Goldstein, Lisa Mirabello, Stephen J. Chanock, Lindsay M. Morton, Sharon A. Savage, Douglas R. Stewart

Summary: The use of publicly available sequencing datasets as controls in rare variant disease association studies can increase the risk of false-positive discoveries. This study systematically investigated the factors that contribute to false-positive discoveries using both public controls and datasets sequenced in their own laboratory. The results showed that using the same variant caller and filtering pipelines significantly reduced the inflation of test statistics. However, differences in library prep kits and sequencers as well as joint vs. separate variant-calling of cases and controls did not affect the false-positive rate. This highlights the risks associated with using public controls and suggests the potential of cloud-based computing to mitigate these issues.

PLOS ONE (2023)

Article Public, Environmental & Occupational Health

Mortality Relative Risks by Smoking, Race/Ethnicity, and Education

Jihyoun Jeon, Maki Inoue -Choi, Yoonseo Mok, Timothy S. McNeel, Jamie Tam, Neal D. Freedman, Rafael Meza

Summary: The study examines the age-specific mortality rates associated with cigarette smoking among different sociodemographic groups in the U.S. It finds that the impact of smoking on mortality varies significantly by factors such as race/ethnicity, gender, and educational attainment.

AMERICAN JOURNAL OF PREVENTIVE MEDICINE (2023)

Letter Medicine, General & Internal

Tea Consumption and All-Cause and Cause-Specific Mortality in the UK Biobank In Response

Maki Inoue-Choi, Yesenia Ramirez, Neal D. Freedman, Erikka Loftfield

ANNALS OF INTERNAL MEDICINE (2023)

Article Oncology

Biomarkers of Tobacco Carcinogenesis in Diverse Populations: Challenges and Opportunities

Arash Etemadi, Christian C. Abnet, Sanford M. Dawsey, Neal D. Freedman

Summary: Biomarkers can provide unique information about cancer risk factors by measuring the internal dose of carcinogens. Smoke-related biomarkers, including tobacco-specific biomarkers and those from exposure to tobacco and non-tobacco pollutants, are commonly studied in relation to cancer. Biomonitoring is superior to self-reported exposure assessment and will continue to be essential to cancer research.

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Article Oncology

Stressful Life Events, Social Support, and Incident Breast Cancer by Estrogen Receptor Status

Wayne R. Lawrence, Jasmine A. McDonald, Faustine Williams, Meredith S. Shiels, Neal D. Freedman, Ziqiang Lin, Jared W. Magnani

Summary: Chronic stress is hypothesized to be associated with breast cancer, but previous studies have shown mixed results. This study examined the association between self-reported stressful life events and incident breast cancer in postmenopausal women, taking into account estrogen receptor (ER) status and social support. The results showed that there was no relationship between stressful life events and ER-positive breast cancer, but there was an increased risk of ER-negative breast cancer in women with higher levels of stressful life events. This association was stronger in widowed women. Social support did not modify the relationship between stressful life events and ER-negative breast cancer.

CANCER PREVENTION RESEARCH (2023)

Article Oncology

Serum perfluorooctane sulfonate and perfluorooctanoate and risk of postmenopausal breast cancer according to hormone receptor status: An analysis in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial

Vicky C. C. Chang, Jongeun Rhee, Sonja I. I. Berndt, Steven C. C. Moore, Neal D. D. Freedman, Rena R. R. Jones, Debra T. T. Silverman, Gretchen L. L. Gierach, Jonathan N. N. Hofmann, Mark P. P. Purdue

Summary: In this nested case-control study, prediagnostic serum levels of PFOS and PFOA were found to be associated with breast cancer risk, particularly for hormone receptor-positive tumors, providing evidence of a possible positive association.

INTERNATIONAL JOURNAL OF CANCER (2023)

Article Oncology

Cancer mortality rates by racial and ethnic groups in the United States, 2018-2020

Anika T. Haque, Amy Berrington de Gonzalez, Yingxi Chen, Emily A. Haozous, Maki Inoue-Choi, Wayne R. Lawrence, Jennifer K. McGee-Avila, Anna M. Napoles, Eliseo J. Perez-Stable, Kekoa Taparra, Jacqueline B. Vo, Neal D. Freedman, Meredith S. Shiels

Summary: The study estimated cancer death rates among different racial and ethnic groups in the United States from 2018 to 2020. The results found significant disparities in cancer death rates, with the highest rates observed among Black individuals and Native Hawaiian and Pacific Islander (NHPI) individuals. Separating NHPI and Asian individuals revealed large differences in cancer mortality between the two groups that were previously combined in vital statistics data.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Oncology

Lung cancer risk discrimination of prediagnostic proteomics measurements compared with existing prediction tools

Xiaoshuang Feng, Wendy Yi-Ying Wu, Justina Ucheojor Onwuka, Zahra Haider, Karine Alcala, Karl Smith-Byrne, Hana Zahed, Florence Guida, Renwei Wang, Julie K. Bassett, Victoria Stevens, Ying Wang, Stephanie Weinstein, Neal D. Freedman, Chu Chen, Lesley Tinker, Therese Haugdahl Nost, Woon-Puay Koh, David Muller, Sandra M. Colorado-Yohar, Rosario Tumino, Rayjean J. Hung, Christopher Amos, Xihong Lin, Xuehong Zhang, Alan A. Arslan, Maria-Jose Sanchez, Elin Pettersen Sorgjerd, Gianluca Severi, Kristian Hveem, Paul Brennan, Arnulf Langhammer, Roger L. Milne, Jian-Min Yuan, Beatrice Melin, Mikael Johansson, Hilary A. Robbins, Mattias Johansson

Summary: This study aimed to develop a proteomics-based risk model for lung cancer and compare its performance with a smoking-based risk model and a commercially available autoantibody biomarker test. We conducted a case-control study in 6 prospective cohorts, involving 624 lung cancer participants and 624 smoking-matched cancer free participants. The protein-based risk model showed promise in predicting incident lung cancer and outperformed the standard risk prediction model and the commercialized EarlyCDT-Lung.

JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2023)

Article Biochemistry & Molecular Biology

Genetically adjusted PSA levels for prostate cancer screening

Linda Kachuri, Thomas J. Hoffmann, Yu Jiang, Sonja I. Berndt, John P. Shelley, Kerry R. Schaffer, Mitchell J. Machiela, Neal D. Freedman, Wen-Yi Huang, Shengchao A. Li, Ryder Easterlin, Phyllis J. Goodman, Cathee Till, Ian Thompson, Hans Lilja, Stephen K. Van Den Eeden, Stephen J. Chanock, Christopher A. Haiman, David V. Conti, Robert J. Klein, Jonathan D. Mosley, Rebecca E. Graff, John S. Witte

Summary: Prostate-specific antigen (PSA) screening for prostate cancer remains controversial due to overdiagnosis and overtreatment. However, accounting for genetic determinants of PSA variation may improve screening accuracy.

NATURE MEDICINE (2023)

Article Oncology

Opportunities for Achieving the Cancer Moonshot Goal of a 50% Reduction in Cancer Mortality by 2047

Meredith S. Shiels, Stanley Lipkowitz, Nicole G. Campos, Mark Schiffman, John T. Schiller, Neal D. Freedman, Amy Berrington de Gonzalez

Summary: President Biden and First Lady Dr. Biden have reignited the Cancer Moonshot with the goal of reducing age-standardized cancer mortality rates by at least 50% in the United States over the next 25 years. From 2000 to 2019, overall cancer death rates declined, driven by significant decreases in lung, colorectal, and breast cancer mortality. However, progress for other cancer types was less promising, highlighting the need for new strategies. Achieving the Moonshot goal requires maintaining or accelerating progress in controlling lung, colorectal, and breast cancer deaths, and developing new approaches for prostate, liver, pancreatic, and other cancers.

CANCER DISCOVERY (2023)

Article Environmental Sciences

A metabolomic investigation of serum perfluorooctane sulfonate and perfluorooctanoate

Jongeun Rhee, Erikka Loftfield, Demetrius Albanes, Tracy M. Layne, Rachael Stolzenberg-Solomon, Linda M. Liao, Mary C. Playdon, Sonja I. Berndt, Joshua N. Sampson, Neal D. Freedman, Steven C. Moore, Mark P. Purdue

Summary: This study aimed to investigate the biological effects of PFOS and PFOA on the human body. Through metabolomic analysis, several metabolites associated with PFOS and PFOA were identified, with lipids and xenobiotics being the most common types. These findings provide insights into the potential hazards of PFOS and PFOA.

ENVIRONMENT INTERNATIONAL (2023)

Meeting Abstract Oncology

Association of genetic ancestry with lung-cancer risk in White and Black eversmokers.

Courtney D. Dill, Dontray Trump, Rebecca Landy, Li Cheung, Wen-Yi Huang, Sonja Berndt, Neal Freedman, Hormuzd Katki

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

Meeting Abstract Oncology

Association of genetic ancestry with lung-cancer risk in White and Black ever-smokers

Courtney D. Dill, Dontray Trump, Rebecca Landy, Li Cheung, Wen-Yi Huang, Sonja Berndt, Neal Freedman, Hormuzd Katki

CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2023)

暂无数据